Back to Search
Start Over
Comprehensive Analysis of Receptor Status, Histopathological Classifications (B1–B5), and Cumulative Histological Dimensions in Breast Cancer: Predictors of Malignancy and Diagnostic Implications.
- Source :
-
Cancers . Oct2024, Vol. 16 Issue 20, p3471. 16p. - Publication Year :
- 2024
-
Abstract
- Simple Summary: The aim of this study was to assess the impact of various factors—such as age, age at menarche, age at first childbirth, number of births, body mass index (BMI), living environment (rural vs. urban), and other factors later discussed—on the likelihood of developing breast cancer. This article's original research was based on data gathered from 687 breast biopsies, which were analyzed through comparative analysis and regression analysis to identify possible predictors for malignancy and tumor size. The comparative analysis and regression models in this study provide deeper insights into the roles of various variables, particularly positive hormonal receptor status, in malignancy. Introduction: Breast cancer has become one of the most serious and widespread public health concerns globally, affecting an increasing number of women—and, in rare cases, men—across the world. It is the most common cancer among women across all countries. In this study, we aimed to evaluate the influence of demographic factors, medical and reproductive history, diagnostic techniques, and hormone receptor status on the development and progression of breast cancer. Materials and Methods: A total of 687 female patients from Romania underwent standard breast examination techniques, including clinical breast examination, mammography, ultrasonography, and, ultimately, breast biopsy. Statistical analysis was performed using the R programming language and RStudio software. The study included a comparative analysis and a prediction analysis for malignancy and tumor size (cumulative histological dimension) through logistic and linear regression models. Results: The comparative analysis identified several variables associated with malignancy: older age (p < 0.001), non-vulnerability (p = 0.04), no daily physical activity (p = 0.002), no re-biopsy (p < 0.001), immunohistochemistry use (p < 0.001), use of larger gauge needles (p < 0.001), ultrasound-guided biopsy (p < 0.001), and vacuum biopsy (p < 0.001). The hormone receptor statuses—estrogen receptor (ER), progesterone receptor (PR), and androgen receptor (AR)—showed statistically significant differences in distribution across breast cancer B classifications. Logistic regression analysis identified ER, PR, and age as significant predictors of malignancy. Linear regression analysis revealed histopathological results, living environment, geographical region, vulnerability, prior breast examination, and the number of histological fragments as significant predictors of cumulative histological dimension. Conclusions: Our predictive models demonstrate the impact of demographic factors, medical history, diagnostic techniques, and hormone receptor status on breast cancer development and progression, accounting for a significant portion of the variance in malignancy and cumulative histological dimension. [ABSTRACT FROM AUTHOR]
- Subjects :
- *BREAST tumor risk factors
*BREAST ultrasound
*REPRODUCTIVE history
*RISK assessment
*BREAST exams
*BIOPSY
*PROGESTERONE receptors
*PREDICTION models
*BODY mass index
*BREAST tumors
*LOGISTIC regression analysis
*RESIDENTIAL patterns
*DESCRIPTIVE statistics
*AGE distribution
*POPULATION geography
*ESTROGEN receptors
*IMMUNOHISTOCHEMISTRY
*SOCIAL context
*MENARCHE
*MAMMOGRAMS
*PARITY (Obstetrics)
*SOCIODEMOGRAPHIC factors
*GYNECOLOGIC diagnosis
*DATA analysis software
*COMPARATIVE studies
*DISEASE susceptibility
*DISEASE progression
*REGRESSION analysis
*ANDROGEN receptors
*CHILDBIRTH
*BLOOD
Subjects
Details
- Language :
- English
- ISSN :
- 20726694
- Volume :
- 16
- Issue :
- 20
- Database :
- Academic Search Index
- Journal :
- Cancers
- Publication Type :
- Academic Journal
- Accession number :
- 180558586
- Full Text :
- https://doi.org/10.3390/cancers16203471